Business Context and Reporting Period
Healthcare Triangle, Inc. (HCTI) filed a Form 8-K on June 16, 2025, reporting the completion of an acquisition. The Company, an emerging growth company listed on Nasdaq, entered into an Asset Transfer Agreement with Niyama Healthcare, Inc. to acquire assets and equity interests related to Mental Health and Hospital Information Systems technology in India, South East Asia, and Europe.
Key Financial Metrics and Transaction Details
The total consideration for the acquisition is $5.7 million, structured as follows:
- Cash: $1.5 million total ($1.2 million paid at closing; $300,000 deferred up to 120 days post-closing).
- Equity: Restricted common stock valued at $3.0 million (calculated at $0.00868 per share).
- Earn-out: Up to $1.2 million contingent on first-year financial performance targets to be agreed within 90 days.
The acquisition includes software intellectual property, customer contracts, regulatory permits, and 100% equity interest in Ezovion Solutions Private Limited. The transaction excludes all liabilities and obligations of the Seller outstanding as of the closing date.
Material Changes and Operational Impact
The primary material change is the expansion of the Company's asset base and geographic footprint through the acquisition of Niyama Healthcare's technology and equity interests. The acquisition closed on June 16, 2025. A transition period is established through August 15, 2025, during which the Seller will support operational continuity, including revenue collection and payroll processing. Revenues collected by the Seller on behalf of the Company will be remitted by August 15, 2025, with subsequent revenues remitted within five business days of receipt.
Guidance, Risks, and Contingencies
The filing contains forward-looking statements regarding the integration timeline and future performance, which are subject to risks and uncertainties. Key contingencies include:
- Earn-out Performance: Up to $1.2 million in additional consideration depends on meeting financial targets to be defined within 90 days.
- Indemnification: The Seller has agreed to indemnify the Company against liabilities arising from breaches of representations, covenants, or pre-closing conduct.
- Financial Reporting: Required financial statements for the acquisition will be filed in an amendment to this report within 71 calendar days.
The filing does not provide specific revenue, profit, or cash flow metrics for the Company's ongoing operations or the acquired entity's historical performance.
Investor Verification Checklist
- Verify the specific first-year financial performance targets required to trigger the $1.2 million earn-out payment.
- Confirm the exact number of restricted shares issued based on the $3.0 million valuation and the $0.00868 share price.
- Monitor the upcoming amendment to the 8-K (due within 71 days) for the required pro forma financial statements.
- Assess the impact of the deferred $300,000 cash payment on the Company's immediate liquidity.
- Review the transition plan details to ensure seamless revenue collection and system integration by August 15, 2025.